More patients with early-stage breast cancer may be able to avoid chemotherapy in the future
Thursday, February 16, 2017 - 13:31
in Health & Medicine
Women with early-stage breast cancer who had an intermediate risk recurrence score (RS) from a 21-gene expression assay had similar outcomes, regardless of whether they received chemotherapy, a new study has found.